Amyloid diseases - Small drugs lead the attack

被引：18

作者：

Iversen, L ^{[1
]}

机构：

[1] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 3QD, England

来源：

NATURE | 2002年 / 417卷 / 6886期

关键词：

D O I：

10.1038/417231a

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Many human disorders — a well-known example being Alzheimer's disease — are characterized by the misfolding and aggregation of key proteins. New small-molecule drugs may help to destabilize these aggregates.

引用

页码：231 / 233

页数：2

共 14 条

[1] Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].

Bard, F ;

Cannon, C ;

Barbour, R ;

Burke, RL ;

Games, D ;

Grajeda, H ;

Guido, T ;

Hu, K ;

Huang, JP ;

Johnson-Wood, K ;

Khan, K ;

Kholodenko, D ;

Lee, M ;

Lieberburg, I ;

Motter, R ;

Nguyen, M ;

Soriano, F ;

Vasquez, N ;

Weiss, K ;

Welch, B ;

Seubert, P ;

Schenk, D ;

Yednock, T .

NATURE MEDICINE, 2000, 6 (08) :916-919

[2] Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice [J].

Cherny, RA ;

Atwood, CS ;

Xilinas, ME ;

Gray, DN ;

Jones, WD ;

McLean, CA ;

Barnham, KJ ;

Volitakis, I ;

Fraser, FW ;

Kim, YS ;

Huang, XD ;

Goldstein, LE ;

Moir, RD ;

Lim, JT ;

Beyreuther, K ;

Zheng, H ;

Tanzi, RE ;

Masters, CL ;

Bush, AI .

NEURON, 2001, 30 (03) :665-676

[3] STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID-P COMPONENT [J].

EMSLEY, J ;

WHITE, HE ;

OHARA, BP ;

OLIVA, G ;

SRINIVASAN, N ;

TICKLE, IJ ;

BLUNDELL, TL ;

PEPYS, MB ;

WOOD, SP .

NATURE, 1994, 367 (6461) :338-345

[4] Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization [J].

Findeis, MA .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01) :76-84

[5]

GARCEAU D, 2002, 7 INT GEN SPRINGF AL

[6]

GERVAIS F, 2002, 7 INT GEN SPRINGF AL

[7]

HIND CRK, 1984, LANCET, V2, P376

[8] Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease [J].

Korth, C ;

May, BCH ;

Cohen, FE ;

Prusiner, SB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) :9836-9841

[9]

MASTERS CL, 2002, 7 INT GEN SPRINGF AL

[10] Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis [J].

Pepys, MB ;

Herbert, J ;

Hutchinson, WL ;

Tennent, GA ;

Lachmann, HJ ;

Gallimore, JR ;

Lovat, LB ;

Bartfai, T ;

Alanine, A ;

Hertel, C ;

Hoffmann, T ;

Jakob-Roetne, R ;

Norcross, RD ;

Kemp, JA ;

Yamamura, K ;

Suzuki, M ;

Taylor, GW ;

Murray, S ;

Thompson, D ;

Purvis, A ;

Kolstoe, S ;

Wood, SP ;

Hawkins, PN .

NATURE, 2002, 417 (6886) :254-259

← 1 2 →